Nigeria : New HIV Drug May Exclude Vulnerable Populations
|
The recent approval of Yeztugo, a twice-yearly injectable
medication for HIV prevention, has sparked global debate as health
experts warn that its ... |
FDA slaps clinical hold on multiple Gilead HIV trials
Gilead has been hit with a clinical hold from the FDA for five tests of its experimental HIV combination treatment amid safety concerns. View article...